An Exploratory Study of Penpulimab Combined With Anlotinib in Neoadjuvant Treatment of Resectable Stage II-IIIB Non-small Cell Lung Cancer
Latest Information Update: 08 May 2024
At a glance
- Drugs Catequentinib (Primary) ; Penpulimab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms pcwaintrl
Most Recent Events
- 26 May 2022 New trial record